Sponsors of The Hare & Tortoise New Quarter Park 8K Run/Walk
There is no reliable and easy-to-administer early detection test for Ovarian Cancer and the research is dramatically underfunded from a survival perspective. The death rate has remained stagnant for 30 years. Survivorship will not improve without greatly increasing and accelerating the amount of research. Ovarian Cancer lags behind advances made with many other cancers.
Early recognition of symptoms is the best way to save women’s lives. Research shows that about 90% of women with early stage Ovarian Cancer do experience symptoms. Without increased education many women and their doctors will ignore or misinterpret these symptoms.
The money raised will fund and deliver an educational program in the greater Williamsburg area. Hopefully money will be available to also pay for some deductibles, and co-pays where otherwise treatment could not be possible. No administrative charges will be deducted.
The need is great, the problem is not going away and lives are at risk. Please help us meet this very important challenge by becoming a sponsor. By supporting this event, your funds will permit us to raise public awareness and ensure a more healthy future for all women – our wives, our mothers, our granddaughters, our sisters and our friends.
We look forward to hearing from you and hope you will join us in this fight.
The Sentara Williamsburg Regional Medical Auxiliary is inviting you to join us as a Contributing Sponsor of The Inaugural Karene O’Hare Memorial Run for Ovarian Cancer. The event is The Hare & Tortoise New Quarter Park 8k Run/Walk which will be held on Saturday, September 12. Sponsorships run from $150 to $500. Your sponsorship will help make our event a financial success. A sponsorship package can be down loaded below.
We are seeking support in our fight to save women from dying needlessly from Ovarian Cancer. Ovarian Cancer – it whispers so listen. It is the deadliest of all gynecologic cancers and the fifth leading cause of cancer deaths among American women. One in 72 American women will be diagnosed with it during their lifetime and one in 95 American women will die from it. About 20,000 American women are diagnosed with Ovarian Cancer each year and about 15,000 American women will die from the disease in 2009.
Ovarian Cancer is difficult to diagnose because the symptoms are subtle and easily confused with other conditions. In cases where Ovarian Cancer is detected before it has spread beyond the ovaries, nine out of 10 women will survive for more than five years. However, only 19% of Ovarian Cancer cases in the United States are diagnosed at this early stage. Approximately 75% of Ovarian Cancer cases are diagnosed at an advanced stage after the cancer has spread beyond the ovary. The over-all five year survival rate is approximately 46%. The five year survival rate for cervical cancer is 72% and for breast cancer it is 89 %.
